Skip to main content
Home
FULL MENU Close Menu
Home
Home

Steven R. Goldstein, MD

News

Skilled US imaging of the adnexal mass: Starting point

Author:
Steven R. Goldstein, MD
Ilan E. Timor-Tritsch, MD

Whether you scan the patient yourself or refer her to an ultrasonography lab, you need to be able to identify both physiologic and pathologic...

  • Read More

News

OSTEOPOROSIS

Author:
Steven R. Goldstein, MD

New data enhance our understanding of the effects of some contraceptives and key SERMs on the skeletal health of users

  • Read More

News

The case for chemoprevention as a tool to avert breast cancer

Author:
Steven R. Goldstein, MD

Women at high risk of invasive breast cancer can elect chemoprevention with tamoxifen or raloxifene. An aromatase inhibitor may one day be an...

  • Read More

News

OSTEOPOROSIS

Author:
Steven R. Goldstein, MD

  • Read More

News

OSTEOPOROSIS

Author:
Steven R. Goldstein, MD

Recent data refine our understanding of how to use key drugs, particularly bisphosphonates, zoledronic acid, recombinant PTH, and raloxifene

  • Read More

News

Shoulder dystocia: Clarifying the care of an old problem

Author:
Steven R. Goldstein, MD

Should maternal pushing stop once dystocia is diagnosed? Here’s light on the standard of care.

  • Read More

News

Does bone loss resume when alendronate is discontinued?

Author:
Steven R. Goldstein, MD

  • Read More

News

Osteopenia: When to intervene?

Author:
Steven R. Goldstein, MD

Why fracture risk assessment should rely on a constellation of factors—not just a numerical bone-density value

  • Read More

News

Preventing fragility fractures: Effective drugs and doses

Author:
Steven R. Goldstein, MD

The latest data from well-designed trials, including FACT, CORE, and MOBILE, have enlightened us on efficacy, tolerability, and patient-friendly...

  • Read More

News

Aromatase inhibitors and breast cancer? Don’t write off tamoxifen

Author:
Steven R. Goldstein, MD

  • Read More

News

Reducing the risk of breast cancer: Key trials and their impact on practice

Author:
Steven R. Goldstein, MD

An expert sifts the data regarding chemopreventive options and expands on current guidelines for endometrial cancer screening of tamoxifen users...

  • Read More

Pages

  • « first
  • 1
  • 2

Privacy Policy

Do Not Sell My Personal Information

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2021 Frontline Medical Communications Inc., Parsippany, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close